(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | 5.04K | |
Other cash income from operating activities | --5.04K | ---- |
Cash paid | -37.37%-983.98K | -716.31K |
Payments to suppliers for goods and services | -37.37%-983.98K | ---716.31K |
Operating cash flow | -36.66%-978.94K | ---716.31K |
Investing cash flow | ||
Cash flow from continuing investing activities | -122.61%-2.93M | -1.32M |
Capital expenditure reported | -135.58%-2.9M | ---1.23M |
Net PPE purchase and sale | 67.29%-27.53K | ---84.18K |
Cash from discontinued investing activities | ||
Investing cash flow | -122.61%-2.93M | ---1.32M |
Financing cash flow | ||
Cash flow from continuing financing activities | -52.14%2.39M | 5M |
Net common stock issuance | -52.14%2.39M | --5M |
Cash from discontinued financing activities | ||
Financing cash flow | -52.14%2.39M | --5M |
Net cash flow | ||
Beginning cash position | 2,577.31%3.08M | --115K |
Current changes in cash | -151.24%-1.52M | --2.96M |
End cash Position | -49.33%1.56M | --3.08M |
Free cash from | -92.33%-3.91M | ---2.03M |
Accounting Standards | US-GAAP | US-GAAP |
No Data
No Data